Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01.

ABSTRACT:

Purpose

Identifying axial length growth rate as an indicator of fast progression before initiating atropine 0.01% for myopia progression in children.

Method

From baseline, axial length growth over six months was measured prospectively. Subjects were then initiated on atropine 0.01% if axial length growth was greater than 0.1mm per 6 months (fast progressors), axial length and spherical equivalent change measurements recorded every six months. The rate of change was compared to the baseline pre-treatment rate. If axial length change was below the threshold, subjects received monitoring only.

Results

73 subjects were identified as fast progressors and commenced atropine 0.01%, (mean baseline refraction of OD -2.9±1.6, OS -2.9±1.8 and a mean baseline axial length OD 24.6

SUBMITTER: Rose LVT 

PROVIDER: S-EPMC8282033 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature